IFNA1 and hepatocellular carcinoma: Given the difficulty of comparing SVR and non-SVR to IFN-free therapy due to the high effectiveness of IFN-free therapy, further studies comparing SVR to IFN-free therapy and SVR to IFN are needed to evaluate the effects of SVR to IFN-free therapy on HCC occurrence.